Skip to main content
Wolfson Institute of Population Health

Dr David Jolliffe, PhD

David

Barts Charity Lecturer

Centre: Centre for Public Health & Policy

Email: d.a.jolliffe@qmul.ac.uk

Profile

I am an early career researcher at Queen Mary, University of London, where I completed my PhD on genetic risk factors for vitamin D deficiency and acute respiratory infections. I was recently awarded a Barts Charity Lectureship to conduct a n=6,200 phase 3 randomised controlled trial of high- vs. low-dose vitamin D supplementation to reduce risk and severity of acute respiratory infections, including COVID-19, in UK adults with sub-optimal vitamin D status.

I am also a co-investigator of the COVIDENCE UK longitudinal cohort study which was launched in response to the outbreak of COVID-19 disease, and aims to advance our understanding of risk factors for coronavirus disease; discover how quickly people recover from the disease and track any long-term complications; evaluate the impact of coronavirus on the physical, mental and economic wellbeing of the UK population, and establish a platform for future research on coronavirus.

Research

Research Interests:

Acute respiratory tract infections and immunomodulatory effects of micronutrients.

Publications

Please click through to see a complete list of David's publications.

Featured publications

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.

  • Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, Bergman P, Bischoff-Ferrari HA, Borzutzky A, Damsgaard CT, Dubnov-Raz G, Esposito S, Gilham C, Ginde AA, Golan-Tripto I, Goodall EC, Grant CC, Griffiths CJ, Hibbs AM, Janssens W, Khadilkar AV, Laaksi I, Lee MT, Loeb M, Maguire JL, Majak P, Mauger DT, Manaseki-Holland S, Murdoch DR, Nakashima A, Neale RE, Pham H, Rake C, Rees JR, Rosendahl J, Scragg R, Shah D, Shimizu Y, Simpson-Yap S, Trilok-Kumar G, Urashima M, Martineau AR.
  • Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6. Epub 2021 Mar 30.
  • PMID: 33798465

Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.

  • Jolliffe DA, Stefanidis C, Wang Z, Kermani NZ, Dimitrov V, White JH, McDonough JE, Janssens W, Pfeffer P, Griffiths CJ, Bush A, Guo Y, Christenson S, Adcock IM, Chung KF, Thummel KE, Martineau AR.
  • Am J Respir Crit Care Med. 2020 Aug 1;202(3):371-382. doi: 10.1164/rccm.201909-1867OC.
  • PMID: 32186892

Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data.

  • Jolliffe DA, Ganmaa D, Wejse C, Raqib R, Haq MA, Salahuddin N, Daley PK, Ralph AP, Ziegler TR, Martineau AR.
  • Eur Respir J. 2019 Mar 7;53(3):1802003. doi: 10.1183/13993003.02003-2018. Print 2019 Mar.
  • PMID: 30728208

Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials.

  • Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, Camargo CA, Griffiths CJ, Janssens W, Martineau AR.
  • Thorax. 2019 Apr;74(4):337-345. doi: 10.1136/thoraxjnl-2018-212092. Epub 2019 Jan 10.
  • PMID: 30630893

Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data.

  • Jolliffe DA, Greenberg L, Hooper RL, Griffiths CJ, Camargo CA Jr, Kerley CP, Jensen ME, Mauger D, Stelmach I, Urashima M, Martineau AR.
  • Lancet Respir Med. 2017 Nov;5(11):881-890. doi: 10.1016/S2213-2600(17)30306-5. Epub 2017 Oct 3.
  • PMID: 28986128
Back to top